[Alternative treatment options for multidrug-resistant HIV-1 infection - first use of lenacapavir in the Czech Republic].

Luk���� Fleischhans
Author Information
  1. Luk���� Fleischhans: Clinic of Infectious Diseases, Bulovka University Hospital, 1st, 2nd and 3rd Faculty of Medicine, Charles University, Czech Republic, e-mail: lukas.fleischhans@bulovka.cz.

Abstract

In this short communication we describe the phenomenon of multidrug-resistant HIV-1 infection, possible causes and treatment op-tions in these cases. The case report presents the successful use of a drug lenacapavir in a non-adherent patient with HIV infection trea-ted at the HIV center of the Clinic of Infectious Diseases, University Hospital Bulovka, Prague.

MeSH Term

Humans
HIV Infections
HIV-1
Drug Resistance, Multiple, Viral
Quinolones
Anti-HIV Agents
Male
Adult

Chemicals

Quinolones
Anti-HIV Agents

Word Cloud

Created with Highcharts 10.0.0infectionmultidrug-resistantHIV-1treatmentuselenacapavirHIVshortcommunicationdescribephenomenonpossiblecausesop-tionscasescasereportpresentssuccessfuldrugnon-adherentpatienttrea-tedcenterClinicInfectiousDiseasesUniversityHospitalBulovkaPrague[Alternativeoptions-firstCzechRepublic]

Similar Articles

Cited By